Celgene Pays US$100 M for Option to Buy Acetylon and Partners with Array BioPharma
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 8 (Table of Contents)
Published: 10 Aug-2013
DOI: 10.3833/pdr.v2013.i8.1971 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Celgene has agreed to pay Acetylon Pharmaceuticals US$100 M upfront in order to obtain an exclusive option to buy the company at a future date for at least US$500 M and potentially more than US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS